A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer

计划入组 66 人 · 首次发布于 2024 年 10 月 10 日

Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer

计划入组 37 人 · 首次发布于 2022 年 7 月 11 日

Dried Leaf Artemisia (DLA) Compared to Artemisinin Combination Therapy (ACT) vs Malaria

首次发布于 2017 年 6 月 27 日

TKM-PLK1

PLK1 inhibitors (cancer)

Flk1 vaccine (ImClone)

TORL BioTherapeutics Secures $158 Million to Advance ADC Oncology Pipeline

IBRI to Host Inaugural 2026 Global Forum on Science, Philanthropy, and Investment

GRI Bio's GRI-0621 Shows Promise in Phase 2a IPF Trial with Disease-Modifying Potential